IS5401A - Samsetning mónóamínoxídasa hemils og h5-HT1B mótlyfs eða gerandefnis með hlutaverkun - Google Patents

Samsetning mónóamínoxídasa hemils og h5-HT1B mótlyfs eða gerandefnis með hlutaverkun

Info

Publication number
IS5401A
IS5401A IS5401A IS5401A IS5401A IS 5401 A IS5401 A IS 5401A IS 5401 A IS5401 A IS 5401A IS 5401 A IS5401 A IS 5401A IS 5401 A IS5401 A IS 5401A
Authority
IS
Iceland
Prior art keywords
pct
combination
alkyl
monoamine oxidase
oxidase inhibitor
Prior art date
Application number
IS5401A
Other languages
English (en)
Icelandic (is)
Inventor
Berg Stefan
Ross Svante
Thorberg Seth-Olov
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS5401A publication Critical patent/IS5401A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS5401A 1997-09-18 2000-03-14 Samsetning mónóamínoxídasa hemils og h5-HT1B mótlyfs eða gerandefnis með hlutaverkun IS5401A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703376A SE9703376D0 (sv) 1997-09-18 1997-09-18 A new combination
PCT/SE1998/001602 WO1999013878A1 (en) 1997-09-18 1998-09-09 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Publications (1)

Publication Number Publication Date
IS5401A true IS5401A (is) 2000-03-14

Family

ID=20408296

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5401A IS5401A (is) 1997-09-18 2000-03-14 Samsetning mónóamínoxídasa hemils og h5-HT1B mótlyfs eða gerandefnis með hlutaverkun

Country Status (27)

Country Link
US (1) US6159970A (cg-RX-API-DMAC10.html)
EP (1) EP1014986B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001516719A (cg-RX-API-DMAC10.html)
KR (2) KR20010024087A (cg-RX-API-DMAC10.html)
CN (1) CN1278727A (cg-RX-API-DMAC10.html)
AR (1) AR013503A1 (cg-RX-API-DMAC10.html)
AT (1) ATE270889T1 (cg-RX-API-DMAC10.html)
AU (1) AU752719B2 (cg-RX-API-DMAC10.html)
BR (1) BR9812236A (cg-RX-API-DMAC10.html)
CA (1) CA2302204A1 (cg-RX-API-DMAC10.html)
DE (1) DE69825062T2 (cg-RX-API-DMAC10.html)
DK (1) DK1014986T3 (cg-RX-API-DMAC10.html)
EE (1) EE200000146A (cg-RX-API-DMAC10.html)
ES (1) ES2222603T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0100621A2 (cg-RX-API-DMAC10.html)
ID (1) ID25789A (cg-RX-API-DMAC10.html)
IL (1) IL134775A0 (cg-RX-API-DMAC10.html)
IS (1) IS5401A (cg-RX-API-DMAC10.html)
MX (1) MXPA00002616A (cg-RX-API-DMAC10.html)
NO (1) NO20001400L (cg-RX-API-DMAC10.html)
PL (1) PL339368A1 (cg-RX-API-DMAC10.html)
PT (1) PT1014986E (cg-RX-API-DMAC10.html)
SE (1) SE9703376D0 (cg-RX-API-DMAC10.html)
SK (1) SK2832000A3 (cg-RX-API-DMAC10.html)
TR (1) TR200000725T2 (cg-RX-API-DMAC10.html)
WO (1) WO1999013878A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA987804B (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957948A (en) * 1988-05-05 1990-09-18 Interface, Inc. Biocidal protective coating for heat exchanger coils
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
WO2002066454A1 (fr) * 2001-02-21 2002-08-29 Sankyo Company, Limited Derives de chromene
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
CN101448803A (zh) * 2006-03-17 2009-06-03 阿斯利康(瑞典)有限公司 用作5-ht6调节剂的四氢萘
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
PL2475428T3 (pl) 2009-09-11 2015-12-31 Probiodrug Ag Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
CN110179988A (zh) * 2019-07-10 2019-08-30 王大伟 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用
IL321485A (en) * 2022-12-14 2025-08-01 Luminous Mind Inc Treatment of psychological symptoms affecting other medical conditions (PFAOMC)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
ES2162792T3 (es) * 1991-09-18 2002-01-16 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d.
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Also Published As

Publication number Publication date
KR20010024087A (ko) 2001-03-26
PL339368A1 (en) 2000-12-18
DK1014986T3 (da) 2004-10-25
US6159970A (en) 2000-12-12
CA2302204A1 (en) 1999-03-25
BR9812236A (pt) 2000-07-18
DE69825062D1 (de) 2004-08-19
PT1014986E (pt) 2004-10-29
CN1278727A (zh) 2001-01-03
ES2222603T3 (es) 2005-02-01
ATE270889T1 (de) 2004-07-15
WO1999013878A1 (en) 1999-03-25
EP1014986B1 (en) 2004-07-14
AU9193198A (en) 1999-04-05
NO20001400L (no) 2000-05-05
SE9703376D0 (sv) 1997-09-18
NO20001400D0 (no) 2000-03-17
AU752719B2 (en) 2002-09-26
JP2001516719A (ja) 2001-10-02
SK2832000A3 (en) 2000-09-12
ZA987804B (en) 1999-03-18
EE200000146A (et) 2001-02-15
ID25789A (id) 2000-11-02
AR013503A1 (es) 2000-12-27
TR200000725T2 (tr) 2000-08-21
KR20010024084A (ko) 2001-03-26
DE69825062T2 (de) 2005-08-25
EP1014986A1 (en) 2000-07-05
MXPA00002616A (es) 2002-04-24
HUP0100621A2 (hu) 2001-08-28
IL134775A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
SE9703375D0 (sv) A new combination
SE9703376D0 (sv) A new combination
HUP0400365A2 (hu) 3-Fluor-pirrolidinek, mint cukorbetegség elleni szerek és a vegyületeket tartalmazó gyógyszerkészítmények
PE20020566A1 (es) DERIVADOS DE FENILACETAMIDO-PIRAZOLES COMO INHIBIDORES DE LA cdk/CICLINA QUINASA
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
AR041566A1 (es) Derivados de indol utiles para el tratamiento de enfermedades
SE0104332D0 (sv) Therapeutic agents
NO20101069L (no) Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva
BG108420A (en) New indole derivatives with 5-ht6 receptor affinity
MEP12708A (en) Derivatives of n-[phenyl (alkylpiperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics
DK0635015T3 (da) Acylaminoindolderivater som 5-Htl agonister
YU25696A (sh) Postupak dobijanja kombinacije (r)-5-karbamoil-8-fluoro-3- n,n-disupstituisan-amino-3,4-dihloro-2h-1-bezopirana i farmaceutske formulacije koje ih sadrže
SE9603283D0 (sv) New compounds
PE20001234A1 (es) Compuestos azabiciclicos sustituidos de heteroaril-aminoetil/benzisoxazol como antagonistas serotonergicos 5-ht1
DK0706517T3 (da) Pyridazinonderivater med farmaceutisk virkning
SE9804126D0 (sv) New pharmaceutical composition
SE9703374D0 (sv) A new combination
FI945582A0 (fi) Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina
FI940568A0 (fi) Anti-inflammatorisina aineina toimivia oksindoli-1-(N-(alkoksikarbonyyli))karboksamideja ja -1-(N-karboksamido)-karboksamideja
SE9702534D0 (sv) Compounds
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
DK0687257T3 (da) 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister
DK0667860T3 (da) Azaspiroalkan-derivater som terapeutiske midler
AR009445A1 (es) Compuestos n-(piridinilamino)isoindolinas y compuestos relacionados, composiciones farmaceuticas, usos en la fabricacion de medicamentos para eltratamiento de la disfuncion de la memoria y la depresion, procedimiento de preparacion de dichos compuestos y compuestos intermediarios
MX9708072A (es) Combinacion de un inhibidor de la incorporacion de 5-ht con un antagonista 5-ht 1a selectivo.